Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Beloqui

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Molecular Pharmaceutics|March 3, 2025
Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease TreatmentLéo Guilbaud, Cheng Chen, Inês Domingues, et al.
International Journal of Pharmaceutics|January 2, 2016
Nanoparticle transport across in vitro olfactory cell monolayersOihane Gartziandia, Susana Patricia Egusquiaguirre, John Bianco, et al.
Angewandte Chemie (International Ed. in English)|July 31, 2020
Hetero-Diels-Alder Cycloaddition with RAFT Polymers as Bioconjugation PlatformAna Beloqui, Shivshankar R Mane, Marcel Langer, et al.
International Journal of Pharmaceutics|March 15, 2016
Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel diseaseMelissa Guada, Ana Beloqui, Mireille Alhouayek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approachLungile Nomcebo Thwala, Ana Beloqui, Noemi Stefania Csaba, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 12, 2023
Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver diseaseInês Domingues, Cecilia Bohns Michalowski, Valentina Marotti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2016
Reformulating cyclosporine A (CsA): More than just a life cycle management strategyMelissa Guada, Ana Beloqui, M N V Ravi Kumar, et al.
International Journal of Pharmaceutics|December 11, 2023
"Green" synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokineticsEspoir K Kambale, Inês Domingues, Wunan Zhang, et al.
Drug Delivery and Translational Research|April 13, 2024
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver diseaseInês Domingues, Hafsa Yagoubi, Wunan Zhang, et al.
FEBS Letters|September 11, 2007
Catalytic role of conserved HQGE motif in the CE6 carbohydrate esterase familyNieves López-Cortés, Dolores Reyes-Duarte, Ana Beloqui, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Molecular Pharmaceutics|March 3, 2025
Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease TreatmentLéo Guilbaud, Cheng Chen, Inês Domingues, et al.
International Journal of Pharmaceutics|January 2, 2016
Nanoparticle transport across in vitro olfactory cell monolayersOihane Gartziandia, Susana Patricia Egusquiaguirre, John Bianco, et al.
Angewandte Chemie (International Ed. in English)|July 31, 2020
Hetero-Diels-Alder Cycloaddition with RAFT Polymers as Bioconjugation PlatformAna Beloqui, Shivshankar R Mane, Marcel Langer, et al.
International Journal of Pharmaceutics|March 15, 2016
Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel diseaseMelissa Guada, Ana Beloqui, Mireille Alhouayek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approachLungile Nomcebo Thwala, Ana Beloqui, Noemi Stefania Csaba, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 12, 2023
Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver diseaseInês Domingues, Cecilia Bohns Michalowski, Valentina Marotti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2016
Reformulating cyclosporine A (CsA): More than just a life cycle management strategyMelissa Guada, Ana Beloqui, M N V Ravi Kumar, et al.
International Journal of Pharmaceutics|December 11, 2023
"Green" synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokineticsEspoir K Kambale, Inês Domingues, Wunan Zhang, et al.
Drug Delivery and Translational Research|April 13, 2024
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver diseaseInês Domingues, Hafsa Yagoubi, Wunan Zhang, et al.
FEBS Letters|September 11, 2007
Catalytic role of conserved HQGE motif in the CE6 carbohydrate esterase familyNieves López-Cortés, Dolores Reyes-Duarte, Ana Beloqui, et al.
Pageof 11